AI-generated summary
The authors retrospectively reviewed 806 patients with nevus of Ota treated with a Q-switched alexandrite laser at 755 nm. Of 590 patients followed by questionnaire at least 3 years after treatment, 93.9% reportedly achieved complete clearance after an average of 5.2 sessions, and the authors report no long-term adverse effects.
- Participants
- 806
- Who or what was studied
- Patients with nevus of Ota (806 patients, 651 female and 155 male); 590 were followed up by questionnaire at least 3 years after completing treatment
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The study is retrospective and follow-up relied on questionnaires in 590 of the 806 patients, with no control group stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 755 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.